{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:21:21Z","timestamp":1790713281785,"version":"4.1.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1110","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective:<\/jats:title>\n                  <jats:p>To evaluate the feasibility, efficacy and safety of transcatheter arterial chemoembolization (TACE) with HepaSphere for patients with pulmonary or mediastinal metastases from hepatocellular carcinoma (HCC).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>Between June 2009 and January 2018, 14 patients with pulmonary or mediastinal metastases from HCC were treated with TACE with a combination of 1\u20133 chemotherapeutic drugs followed by HepaSphere embolization. As first end point, local tumor response and adverse events were evaluated after the first session of TACE, with Response Evaluation Criteria In Solid Tumors v. 1.1 and Common Terminology Criteria for Adverse Events v. 4 criteria, respectively. Overall survival was evaluated as secondary end point. TACE was repeated on-demand.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>TACE with HepaSphere was well tolerated with acceptable safety profile and no 30\u2009day mortality. 1\u2009month objective response and disease control rate were calculated to be 7.1 and 100%, respectively. Mean tumor size reduction rate was 15.6\u00b19.5% at the first month. Two Grade 3 cytopenia events were seen (14.3 %), however none of the Grade 2 or more post-embolization syndrome was observed. The median overall survival time was 15.0 months and the 1\u2009year, 3\u2009year and 5\u2009year survival rate were, 57.1%, 28.6%, 19.1%, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion:<\/jats:title>\n                  <jats:p>Early experience showed that the transarterial treatment with HepaSphere is safe and effective treatment for patients with pulmonary or mediastinal metastases from HCC.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Advances in knowledge:<\/jats:title>\n                  <jats:p>Currently, the effects of molecular targeted drugs on HCC metastases are limited and side-effects are relatively frequent. In the present study, transarterial treatment might be a promising treatment for HCC metastasis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1259\/bjr.20190407","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T18:07:24Z","timestamp":1583518044000},"source":"Crossref","is-referenced-by-count":19,"title":["Transarterial chemoembolization for pulmonary or mediastinal metastases from hepatocellular carcinoma"],"prefix":"10.1093","volume":"93","author":[{"given":"Atsushi","family":"Hori","sequence":"first","affiliation":[{"name":"Department of Radiology, IGT Clinic, Image Guided Therapy , Osaka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kansai Rosai Hospital , Osaka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Radiology, Tominaga Hospital , Osaka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Osaka University Graduate School of Medicine , Suita, Osaka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Radiology, IGT Clinic, Image Guided Therapy , Osaka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Torii","sequence":"additional","affiliation":[{"name":"Department of Radiology, IGT Clinic, Image Guided Therapy , Osaka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Kennoki","sequence":"additional","affiliation":[{"name":"Department of Radiology, IGT Clinic, Image Guided Therapy , Osaka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Hori","sequence":"additional","affiliation":[{"name":"Department of Radiology, IGT Clinic, Image Guided Therapy , Osaka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"2024050215242142300_b1","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1159\/000448653","article-title":"Long-Term survival after resection of lung metastases from hepatocellular cancer: report of a case and review of the literature","volume":"9","author":"Chelimeda","year":"2016","journal-title":"Case Rep Oncol"},{"key":"2024050215242142300_b2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00268-015-3213-3","article-title":"Clinical significance of multiple pulmonary metastasectomy for hepatocellular carcinoma","volume":"40","author":"Mizuguchi","year":"2016","journal-title":"World J Surg"},{"key":"2024050215242142300_b3","first-page":"621","article-title":"Pulmonary metastasectomy for hepatocellular carcinoma","volume":"67","author":"Chen","year":"2004","journal-title":"J Chin Med Assoc"},{"key":"2024050215242142300_b4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3748\/wjg.v13.i3.414","article-title":"Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma","volume":"13","author":"Uka","year":"2007","journal-title":"World J Gastroenterol"},{"key":"2024050215242142300_b5","first-page":"251","article-title":"Prognosis of hepatocellular carcinoma patients with extrahepatic metastases","volume":"44","author":"Okusaka","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"2024050215242142300_b6","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jvir.2017.06.003","article-title":"Transcatheter arterial chemoembolization with spherical embolic agent in patients with pulmonary or mediastinal metastases from breast cancer","volume":"28","author":"Kennoki","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"2024050215242142300_b7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00270-018-1990-4","article-title":"Superabsorbent polymer microspheres prepared with hypertonic saline to reduce microsphere expansion","volume":"41","author":"Sato","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2024050215242142300_b8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1536\/ihj.3.523","article-title":"A method for arteriography of the bronchial artery","volume":"3","author":"Neyazaki","year":"1962","journal-title":"Jpn Heart J"},{"key":"2024050215242142300_b9","first-page":"463","article-title":"The bronchial circulation. small, but a vital attribute of the lung","volume":"135","author":"Deffebach","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2024050215242142300_b10","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s005950200148","article-title":"Feasibility of induction chemotherapy using bronchial arterial infusion for locally advanced non-small cell lung cancer: a pilot study","volume":"32","author":"Osaki","year":"2002","journal-title":"Surg Today"},{"key":"2024050215242142300_b11","first-page":"44","article-title":"Therapeutic results of non-small cell lung cancer in stage III: combined synchronous irradiation with bronchial artery infusion of CDDP","volume":"55","author":"Murakami","year":"1995","journal-title":"Nihon Igaku Hoshasen Gakkai Zasshi"},{"key":"2024050215242142300_b12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.lungcan.2006.10.008","article-title":"Effective use of multi-arterial infusion chemotherapy for advanced non-small cell lung cancer patients: four clinical specified cases","volume":"55","author":"Nakanishi","year":"2007","journal-title":"Lung Cancer"},{"key":"2024050215242142300_b13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-0032-1326923","article-title":"Bronchial artery embolization","volume":"29","author":"Lorenz","year":"2012","journal-title":"Semin Intervent Radiol"},{"key":"2024050215242142300_b14","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00330-006-0576-8","article-title":"Ectopic origin of bronchial arteries: assessment with multidetector helical CT angiography","volume":"17","author":"Hartmann","year":"2007","journal-title":"Eur Radiol"},{"key":"2024050215242142300_b15","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20140126","article-title":"Current role of hybrid CT\/angiography system compared with C-arm cone beam CT for interventional oncology","volume":"87","author":"Tanaka","year":"2014","journal-title":"Br J Radiol"},{"key":"2024050215242142300_b16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9610(92)90039-T","article-title":"Primary treatment of hepatocellular carcinoma by arterial chemoembolization","volume":"163","author":"Bismuth","year":"1992","journal-title":"Am J Surg"},{"key":"2024050215242142300_b17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejrad.2006.03.002","article-title":"Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer","volume":"59","author":"Xia","year":"2006","journal-title":"Eur J Radiol"},{"key":"2024050215242142300_b18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00270-013-0777-x","article-title":"Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 \u03bcm. safety and efficacy study","volume":"37","author":"Malagari","year":"2014","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2024050215242142300_b19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11604-015-0448-8","article-title":"Transcatheter arterial embolization of hypervascular tumors with HepaSphere: prospective multicenter open label clinical trial of microspheres in Japan","volume":"33","author":"Hiraki","year":"2015","journal-title":"Jpn J Radiol"},{"key":"2024050215242142300_b20","first-page":"1407","article-title":"Transcatheter arterial chemoembolization with super absorbent polymer microspheres for a large lung cystic adenocarcinoma in the left pulmonary cavity","volume":"42","author":"Kennoki","year":"2015","journal-title":"Gan To Kagaku Ryoho"},{"key":"2024050215242142300_b21","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000329602","article-title":"A randomized phase II study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma","volume":"34","author":"van Malenstein","year":"2011","journal-title":"Onkologie"},{"key":"2024050215242142300_b22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00270-010-9975-y","article-title":"Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience","volume":"34","author":"Seki","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2024050215242142300_b23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1743-7563.2012.01542.x","article-title":"Sorafenib in combination with transarterial chemoembolization and bronchial arterial chemoinfusion in the treatment of hepatocellular carcinoma with pulmonary metastasis","volume":"8","author":"Duan","year":"2012","journal-title":"Asia Pac J Clin Oncol"},{"key":"2024050215242142300_b24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejcts.2011.05.052","article-title":"Outcome and survival analysis of pulmonary metastasectomy for hepatocellular carcinoma","volume":"41","author":"Kitano","year":"2012","journal-title":"Eur J Cardiothorac Surg"}],"container-title":["The British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/93\/1110\/20190407\/57376005\/bjr.20190407.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/93\/1110\/20190407\/57376005\/bjr.20190407.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T16:47:33Z","timestamp":1714668453000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/doi\/10.1259\/bjr.20190407\/7452149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":24,"journal-issue":{"issue":"1110","published-online":{"date-parts":[[2020,3,18]]},"published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1259\/bjr.20190407","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5,1]]},"published":{"date-parts":[[2020,3,18]]},"article-number":"20190407"}}